30274985 |
Robust Activity of Avapritinib, Potent and Highly Selective Inhibitor of Mutated KIT, in Patient-derived Xenograft Models of Gastrointestinal Stromal Tumors
Gebreyohannes, YK,
Gardino, AK,
Wellens, J,
Schöffski, P,
Wozniak, A,
Vanleeuw, U,
Sciot, R,
Lengauer, C,
Cornillie, J,
Evans, E,
Zhai, ME,
Debiec-Rychter, M
|
Clin. Cancer Res. |
2019 |
31309543 |
Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies
Griffin, JD,
Yang, J,
Buhrlage, SJ,
Letard, S,
Stone, RM,
Tiv, HL,
Meng, C,
Case, AE,
Gokhale, PC,
Liu, X,
Gray, N,
Sattler, M,
Dubreuil, P,
Weisberg, E,
Wang, J,
Adamia, S
|
Br. J. Haematol. |
2019 |
30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Heinrich, MC,
Ketzer, J,
Bauer, S,
Zhu, M,
Presnell, A,
Raut, CP,
George, S,
Mannan, AM,
Serrano, C,
Yu, C,
Sicinska, E,
Tao, DL,
Rubin, BP,
Fletcher, JA,
Mariño-Enríquez, A,
Demetri, GD,
Eilers, G,
Czaplinski, JT,
McKinley, A
|
Br. J. Cancer |
2019 |
29093181 |
A precision therapy against cancers driven by KIT/PDGFRA mutations
Heinrich, MC,
Zhang, Y,
Hodous, BL,
Shutes, A,
Lengauer, C,
Evans, EK,
Kohl, N,
Wolf, B,
Schöffski, P,
Zhu, XJ,
Kim, JL,
Gebreyohannes, YK,
Gardino, AK,
Wozniak, A,
DiPietro, L,
Lydon, N,
Wilson, K,
Brooijmans, N,
Schmidt-Kittler, O,
Boral, A,
Miller, S,
LaBranche, TP,
Deangelo, DJ,
Davis, A,
Guzi, T,
Wilson, D
|
Sci Transl Med |
2017 |
16189265 |
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
Fabbro, D,
Valent, P,
Sonneck, K,
Gleixner, KV,
Böhm, A,
Samorapoompichit, P,
Aichberger, KJ,
Gruze, A,
Sillaber, C,
Mayerhofer, M,
Pickl, WF,
Manley, PW,
Derdak, S
|
Blood |
2006 |
15972446 |
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
Kajiguchi, T,
Durocher, JA,
Gilliland, DG,
Chen, CC,
Heinrich, MC,
Ruan, J,
Lichy, JH,
Coutré, SE,
Galli, SJ,
Wang, Y,
Lilleberg, SL,
George, TI,
Williams, C,
Arber, DA,
Growney, JD,
Neckers, L,
Berubé, C,
Gotlib, J,
Cohen, PS
|
Blood |
2005 |
15790786 |
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412
Griffin, JD,
Gilliland, DG,
Adelsperger, J,
Fabbro, D,
Clark, JJ,
Stone, R,
Growney, JD
|
Blood |
2005 |